Provided By GlobeNewswire
Last update: Nov 6, 2024
Revenue Rose to $8.2 Million
Company Reaffirms Timeline for Regulatory Submission to U.S. FDA
Q3 2024 Overview
Read more at globenewswire.com1.95
-0.04 (-2.01%)
NASDAQ:MDAIW (2/21/2025, 8:00:01 PM)
0.49
+0.02 (+3.73%)
Find more stocks in the Stock Screener